Stability of methylnicotinate in aqueous solution as utilized in the 'niacin patch test'

<p>Abstract</p> <p>Background</p> <p>The topical application of methylnicotinate results in a localized vasodilatatory response which has been found to differ from that observed to occur in healthy controls in a variety of medical conditions. The stability of the drug i...

Full description

Bibliographic Details
Main Authors: Katzman Martin, Ross Brian M
Format: Article
Language:English
Published: BMC 2008-09-01
Series:BMC Research Notes
Online Access:http://www.biomedcentral.com/1756-0500/1/89
id doaj-911d0f61376d424ab56331f2add6d5cd
record_format Article
spelling doaj-911d0f61376d424ab56331f2add6d5cd2020-11-25T02:01:56ZengBMCBMC Research Notes1756-05002008-09-01118910.1186/1756-0500-1-89Stability of methylnicotinate in aqueous solution as utilized in the 'niacin patch test'Katzman MartinRoss Brian M<p>Abstract</p> <p>Background</p> <p>The topical application of methylnicotinate results in a localized vasodilatatory response which has been found to differ from that observed to occur in healthy controls in a variety of medical conditions. The stability of the drug in aqueous solution is unclear while difficulties can be encountered when preparing methylnicotinate solutions for this purpose. To aid in the determination of how long solutions of the drug should be stored before discarding we have used a collection of aged batches of methylnicotinate to determine the stability of the drug in aqueous solution.</p> <p>Findings</p> <p>The degradation of methylnicotinate was determined in batches which had been stored at 4°C for between 5 and 1062 days prior to analysis by High Performance Liquid Chromatography. The major degradation product of methylnicotinate was nicotinic acid which formed at an approximate rate of 0.5% of the starting methylnicotinate concentration per annum. Furthermore, the ability of methylnicotinate solutions of different ages to induce vasodilatation was assessed in healthy volunteers. No significant difference in vasodilatatory response was apparent between batches which had been stored for between zero and 1057 days.</p> <p>Conclusion</p> <p>Methylnicotinate exhibits excellent chemical and biological stability in solution facilitating its use in clinical applications.</p> http://www.biomedcentral.com/1756-0500/1/89
collection DOAJ
language English
format Article
sources DOAJ
author Katzman Martin
Ross Brian M
spellingShingle Katzman Martin
Ross Brian M
Stability of methylnicotinate in aqueous solution as utilized in the 'niacin patch test'
BMC Research Notes
author_facet Katzman Martin
Ross Brian M
author_sort Katzman Martin
title Stability of methylnicotinate in aqueous solution as utilized in the 'niacin patch test'
title_short Stability of methylnicotinate in aqueous solution as utilized in the 'niacin patch test'
title_full Stability of methylnicotinate in aqueous solution as utilized in the 'niacin patch test'
title_fullStr Stability of methylnicotinate in aqueous solution as utilized in the 'niacin patch test'
title_full_unstemmed Stability of methylnicotinate in aqueous solution as utilized in the 'niacin patch test'
title_sort stability of methylnicotinate in aqueous solution as utilized in the 'niacin patch test'
publisher BMC
series BMC Research Notes
issn 1756-0500
publishDate 2008-09-01
description <p>Abstract</p> <p>Background</p> <p>The topical application of methylnicotinate results in a localized vasodilatatory response which has been found to differ from that observed to occur in healthy controls in a variety of medical conditions. The stability of the drug in aqueous solution is unclear while difficulties can be encountered when preparing methylnicotinate solutions for this purpose. To aid in the determination of how long solutions of the drug should be stored before discarding we have used a collection of aged batches of methylnicotinate to determine the stability of the drug in aqueous solution.</p> <p>Findings</p> <p>The degradation of methylnicotinate was determined in batches which had been stored at 4°C for between 5 and 1062 days prior to analysis by High Performance Liquid Chromatography. The major degradation product of methylnicotinate was nicotinic acid which formed at an approximate rate of 0.5% of the starting methylnicotinate concentration per annum. Furthermore, the ability of methylnicotinate solutions of different ages to induce vasodilatation was assessed in healthy volunteers. No significant difference in vasodilatatory response was apparent between batches which had been stored for between zero and 1057 days.</p> <p>Conclusion</p> <p>Methylnicotinate exhibits excellent chemical and biological stability in solution facilitating its use in clinical applications.</p>
url http://www.biomedcentral.com/1756-0500/1/89
work_keys_str_mv AT katzmanmartin stabilityofmethylnicotinateinaqueoussolutionasutilizedintheniacinpatchtest
AT rossbrianm stabilityofmethylnicotinateinaqueoussolutionasutilizedintheniacinpatchtest
_version_ 1724954935916756992